Literature DB >> 20843906

High DNA oxidative damage in systemic sclerosis.

Jerome Avouac1, Didier Borderie, Ovanesse Garabed Ekindjian, Andre Kahan, Yannick Allanore.   

Abstract

OBJECTIVE: Several lines of evidence suggest that the generation of reactive oxygen species (ROS) is of major importance in the pathogenesis of SSc. Protein and lipid damage have previously been demonstrated, but scarce data are available on oxidative damage to DNA. In patients with SSc, we evaluated levels of 8-hydroxy-2'-deoxyguanosine (8-oxodG), the main validated biomarker of endogenous oxidative damage to DNA, compared to levels of F2-isoprostane, a product of free radical-mediated peroxidation of arachidonic acid.
METHODS: Urinary levels of 8-oxodG and 8-isoprostaglandin-F(2α) (8-iso-PGF(2α)) were determined by competitive ELISA method in consecutive SSc patients and controls matched for age and sex.
RESULTS: We included 80 unrelated SSc patients (72 women, mean age 56 ± 11 yrs) and 39 controls (33 women, mean age 64 ± 8 yrs). Urinary levels of 8-oxodG/creat and 8-iso-PGF(2α)/creat in SSc patients were found to be higher than in controls (6.5 ng/mg vs 3.7 ng/mg, p = 0.0001; and 11.4 ng/mg vs 4.2 ng/mg, p < 0.0001). In multivariate analysis, 8-oxodG levels were associated with the presence of pulmonary fibrosis on computerized tomography scan, decreased forced vital capacity, and decreased DLCO/alveolar volume. In patients with the diffuse cutaneous subset, a modified Rodnan skin score > 14 was independently associated with 8-oxodG levels. In SSc, 8-oxodG and 8-iso-PGF(2α) values were correlated (r = 0.32; p = 0.005).
CONCLUSION: Our study confirmed marked oxidative stress in SSc. We also found increased values of 8-oxodG in SSc patients and a relevant association with a fibrotic phenotype. The predictive value of this marker and its potential influence on fibrotic disturbances remain to be determined.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20843906     DOI: 10.3899/jrheum.100398

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  21 in total

Review 1.  Emerging horizons of salivary diagnostics for periodontal disease.

Authors:  L Fuentes; M Yakob; D T W Wong
Journal:  Br Dent J       Date:  2014-11       Impact factor: 1.626

2.  Refractory anemia in systemic sclerosis: myelodisplastic syndrome.

Authors:  Gökhan Sargın; Taşkın Şentürk; İrfan Yavaşoğlu
Journal:  Eur J Rheumatol       Date:  2015-03-31

3.  Increased expression of NAPDH oxidase 4 in systemic sclerosis dermal fibroblasts: regulation by transforming growth factor β.

Authors:  Sonsoles Piera-Velazquez; Alma Makul; Sergio A Jiménez
Journal:  Arthritis Rheumatol       Date:  2015-10       Impact factor: 10.995

Review 4.  Role of cellular senescence and NOX4-mediated oxidative stress in systemic sclerosis pathogenesis.

Authors:  Sonsoles Piera-Velazquez; Sergio A Jimenez
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

5.  A Pilot Study of Dimethyl Fumarate in Pulmonary Arterial Hypertension Associated with Systemic Sclerosis.

Authors:  Kristi Kong; Diane Koontz; Christina Morse; Eileen Roth; Robyn T Domsic; Marc A Simon; Eric Stratton; Connor Buchholz; Kimberly Tobin-Finch; Robert Simms; M Patricia George; Paul M Hassoun; Harrison Farber; Robert Lafyatis
Journal:  J Scleroderma Relat Disord       Date:  2021-05-28

6.  Interstitial lung disease is associated with an increased risk of lung cancer in systemic sclerosis: Longitudinal data from the Canadian Scleroderma Research Group.

Authors:  Lama Sakr; Marie Hudson; Mianbo Wang; Elie Younanian; Murray Baron; Sasha Bernatsky
Journal:  J Scleroderma Relat Disord       Date:  2018-04-10

7.  Risk factors for malignancy in systemic sclerosis patients.

Authors:  T Kaşifoğlu; Ş Yaşar Bilge; F Yıldız; G Özen; Y Pehlivan; N Yılmaz; F Tarhan; S Yılmaz; A Küçük; H Emmungil; S S Koca; M Çınar; H Direskeneli; E Erken; G Can; M Özmen; E Gönüllü; B Kisacik; K Aksu; O Karadağ; N Kasifoglu; D Arslantas; F Sahin; G Keser; S Yavuz; M Birlik; A M Onat
Journal:  Clin Rheumatol       Date:  2016-04-27       Impact factor: 2.980

Review 8.  Oxidative stress and antioxidant strategies in dermatology.

Authors:  Jinok Baek; Min-Geol Lee
Journal:  Redox Rep       Date:  2016-03-31       Impact factor: 4.412

9.  Apoptosis modulation as a promising target for treatment of systemic sclerosis.

Authors:  Stéphane Chabaud; Véronique J Moulin
Journal:  Int J Rheumatol       Date:  2011-09-06

10.  New insights into the role of oxidative stress in scleroderma fibrosis.

Authors:  Armando Gabrielli; Silvia Svegliati; Gianluca Moroncini; Donatella Amico
Journal:  Open Rheumatol J       Date:  2012-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.